
Sign up to save your podcasts
Or


Mucus plugging is a challenge in asthma care. It’s thick, sticky mucus that blocks the airways and doesn’t respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control.
In this episode, we break down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published October 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.”
📌INFOGRAPHIC to follow along
RESOURCES:
What is asthma?
What is type 2 inflammation?
When Asthma Is More Than Just Asthma: Type 2 Inflammation
More about dupilumab (Dupixent)
The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.
___
A special collaboration with the American Thoracic Society.
This podcast was made in partnership with Allergy & Asthma Network.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
By The Itch: Allergies, Asthma & Immunology4.3
9292 ratings
Mucus plugging is a challenge in asthma care. It’s thick, sticky mucus that blocks the airways and doesn’t respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control.
In this episode, we break down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published October 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.”
📌INFOGRAPHIC to follow along
RESOURCES:
What is asthma?
What is type 2 inflammation?
When Asthma Is More Than Just Asthma: Type 2 Inflammation
More about dupilumab (Dupixent)
The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.
___
A special collaboration with the American Thoracic Society.
This podcast was made in partnership with Allergy & Asthma Network.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

90,795 Listeners

43,986 Listeners

30,798 Listeners

39,028 Listeners

25,840 Listeners

3,347 Listeners

112,451 Listeners

56,739 Listeners

9,558 Listeners

50 Listeners

50 Listeners

58,305 Listeners

318 Listeners

628 Listeners

11,482 Listeners